• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease.

作者信息

Sniderman Allan D

机构信息

Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine, McGill University Health Centre, Montreal, QB, Canada.

出版信息

Clin Chem. 2021 Nov 1;67(11):1440-1442. doi: 10.1093/clinchem/hvab140.

DOI:10.1093/clinchem/hvab140
PMID:34535997
Abstract
摘要

相似文献

1
ApoB vs non-HDL-C vs LDL-C as Markers of Cardiovascular Disease.载脂蛋白B与非高密度脂蛋白胆固醇及低密度脂蛋白胆固醇作为心血管疾病标志物的比较
Clin Chem. 2021 Nov 1;67(11):1440-1442. doi: 10.1093/clinchem/hvab140.
2
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk.一项关于低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B作为心血管风险标志物的荟萃分析。
Circ Cardiovasc Qual Outcomes. 2011 May;4(3):337-45. doi: 10.1161/CIRCOUTCOMES.110.959247. Epub 2011 Apr 12.
3
An evidence-based analysis of the National Lipid Association recommendations concerning non-HDL-C and apoB.基于证据的分析，探讨了美国国家脂质协会关于非高密度脂蛋白胆固醇（non-HDL-C）和载脂蛋白 B（apoB）的建议。
J Clin Lipidol. 2016 Sep-Oct;10(5):1248-58. doi: 10.1016/j.jacl.2016.07.008. Epub 2016 Aug 2.
4
ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.载脂蛋白B/载脂蛋白A1以及低密度脂蛋白胆固醇/高密度脂蛋白胆固醇与他汀类药物治疗患者心血管风险的预测
Curr Med Res Opin. 2008 Feb;24(2):359-64. doi: 10.1185/030079907x253906.
5
Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.他汀类药物治疗患者的 LDL 胆固醇、非 HDL 胆固醇和载脂蛋白 B 水平与心血管事件风险的关系：一项荟萃分析。
JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366.
6
Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.对于老年男性的心血管疾病和死亡率而言，载脂蛋白A1是比高密度脂蛋白和低密度脂蛋白胆固醇更强的预后标志物。
J Gerontol A Biol Sci Med Sci. 2006 Dec;61(12):1262-6. doi: 10.1093/gerona/61.12.1262.
7
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常：2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.
8
Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment.载脂蛋白B、非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇作为动脉粥样硬化性心血管疾病风险评估的标志物。
Ann Lab Med. 2023 May 1;43(3):221-222. doi: 10.3343/alm.2023.43.3.221. Epub 2022 Dec 22.
9
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?非高密度脂蛋白胆固醇还是载脂蛋白 B：预防动脉粥样硬化性心血管疾病，哪个指标更适合作为靶点？
Curr Cardiol Rep. 2020 Jun 19;22(8):67. doi: 10.1007/s11886-020-01323-z.
10
[What is a good marker for serum cholesterol to identify high-risk patients at general health checks?].[在一般健康检查中，用于识别高危患者的血清胆固醇的良好标志物是什么？]
Rinsho Byori. 2012 Apr;60(4):328-35.

引用本文的文献

1
Saturated fat from dairy sources and cardio-metabolic health: insights from the STANISLAS cohort.来自乳制品的饱和脂肪与心血管代谢健康：斯坦尼斯拉斯队列研究的见解
Eur J Nutr. 2025 Aug 30;64(6):267. doi: 10.1007/s00394-025-03763-1.
2
Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association for Laboratory Medicine.英国血脂检测与报告的标准化；英国心脏协会（HEART UK）与检验医学协会联合声明
Ann Clin Biochem. 2025 Jul;62(4):257-286. doi: 10.1177/00045632251315303. Epub 2025 Jan 31.
3
ApoB/ApoA-Ι is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year.
载脂蛋白B/载脂蛋白A-Ι与主要心血管事件及经皮冠状动脉介入治疗术后患者一年内的再入院风险相关。
Sci Rep. 2025 Jan 6;15(1):996. doi: 10.1038/s41598-024-84092-x.
4
Association of High apoB/apoA1 Ratio with Increased Erythrocytes, Platelet/Lymphocyte Ratio, D-dimer, Uric Acid and Cardiac Remodeling in Elderly Heart Failure Patients: A Retrospective Study.高载脂蛋白B/载脂蛋白A1比值与老年心力衰竭患者红细胞、血小板/淋巴细胞比值、D-二聚体、尿酸升高及心脏重塑的相关性：一项回顾性研究
Int J Gen Med. 2024 May 15;17:2151-2161. doi: 10.2147/IJGM.S465053. eCollection 2024.
5
Apolipoprotein B and Lipid Profile in Italian Children and Adolescents.意大利儿童和青少年的载脂蛋白B与血脂谱
J Cardiovasc Dev Dis. 2024 Jan 29;11(2):44. doi: 10.3390/jcdd11020044.
6
Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing.杂合子家族性高胆固醇血症的分层：影像学、生物标志物和基因检测。
Curr Atheroscler Rep. 2023 Dec;25(12):899-909. doi: 10.1007/s11883-023-01160-9. Epub 2023 Nov 3.
7
The association of apolipoprotein B with chronic kidney disease in the Chinese population.载脂蛋白 B 与中国人群慢性肾脏病的关系。
Front Endocrinol (Lausanne). 2023 Apr 12;14:1083614. doi: 10.3389/fendo.2023.1083614. eCollection 2023.
8
Multi-omic underpinnings of epigenetic aging and human longevity.多组学揭示表观遗传衰老和人类长寿的基础。
Nat Commun. 2023 Apr 19;14(1):2236. doi: 10.1038/s41467-023-37729-w.
9
Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment.载脂蛋白B、非高密度脂蛋白胆固醇和低密度脂蛋白胆固醇作为动脉粥样硬化性心血管疾病风险评估的标志物。
Ann Lab Med. 2023 May 1;43(3):221-222. doi: 10.3343/alm.2023.43.3.221. Epub 2022 Dec 22.
10
Remnants, LDL, and the Quantification of Lipoprotein-Associated Risk in Atherosclerotic Cardiovascular Disease.残粒脂蛋白、LDL 与动脉粥样硬化性心血管疾病脂蛋白相关风险的定量评估。
Curr Atheroscler Rep. 2022 Mar;24(3):133-142. doi: 10.1007/s11883-022-00994-z. Epub 2022 Feb 17.